Wound Healing
Conditions
Interventions
This is a randomized clinical trial of the PROBE type (Prospective, Randomized, Open, Blinded End-point), conducted in the adult Intensive Care Unit of the Hospital de Clínicas de Porto Alegre, involv
Sponsors
Hospital de Clínicas de Porto Alegre
Hospital de Clínicas de Porto Alegre
Eligibility
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Clinical patients aged 18 to 75 years; regardless of gender; length of stay exceeding 24 hours in the ICU; stage 1 pressure ulcer developed during ICU admission; pressure ulcer identified during ICU admission (acquired in another unit); patients/companions who provide prior authorization through an informed consent form
Exclusion criteria
Exclusion criteria: Patients with coexisting dermatological diagnoses, such as burns, drug-related rashes, dermatitis, psoriasis; patients diagnosed with Fournier's and Stevens-Johnson syndromes; post-surgical patients (mobility contraindicated); patients with contraindicated changes in position; those who are hemodynamically unstable (patients using extracorporeal membrane oxygenation - ECMO or patients with adult respiratory distress syndrome - ARDS, prone position); patients who have already undergone photobiomodulation in the same injured area
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assess the improvement in the average score of the NOC outcome, tissue integrity: skin and mucous membranes (1101) | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in the Braden Scale score, improvement in the size and characteristics of the Stage 1 pressure injury, and development of Stage 2 or deep tissue pressure injury | — |
Countries
Brazil
Contacts
Public ContactBelilia Domireth Canga
Hospital de Clínicas de Porto Alegre
Outcome results
None listed